Replies to post #1758 on Immune Pharmaceuticals Inc (fka IMNPQ)

[cash_cow1]

Immune if Pharma partnering with Bristo-Myers for clinical trial study of Berilimumab drug treatment on bulliou pemphigoid. $150 million up front, 270 million in mile stones payment, $15 a share after FDA approval.